Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion

Molecular Cancer Research

Volumn 5, Issue 1, 2007, Pages 21-33

  Sutton, Angela ^a   Friand, Veronique ^a   Brulé Donneger, Severine ^a   Chaigneau, Thomas ^a   Ziol, Marianne ^a   Sainte Catherine, Odile ^a   Poiré, Aurelie ^a   Saffar, Line ^a   Kraemer, Michel ^a   Vassy, Jany ^b   Nahon, Pierre ^a,c   Salzmann, Jean Loup ^a   Gattegno, Liliane ^a,c   Charnaux, Nathalie ^a,c  

^a UNIVERSITÉ PARIS 13   (France)

^b INSERM   (France)

^c HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE RECEPTOR CXCR4; COMPLEMENT COMPONENT C1S; FOCAL ADHESION KINASE; G PROTEIN COUPLED RECEPTOR; GELATINASE B; GLYCOSAMINOGLYCAN; HEPARIN; STRESS ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1; SYNDECAN 4; TUMOR NECROSIS FACTOR ALPHA; XYLAN 1,4 BETA XYLOSIDASE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INVASION; CELL CYCLE; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR GROWTH;

CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES, CXC; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSAMINOGLYCANS; HUMANS; LIVER NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; STROMAL CELLS; SYNDECAN-1; SYNDECAN-2; SYNDECAN-4; TYROSINE;

EID: 33846985321     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-06-0103     Document Type: Article

References (53)

1. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675-705.
2. Burger JA, Kipps TJ. CXCR4: a key receptor in the cross talk between tumor cells and their microenvironment. Blood 2006;107:1761-7.
3. Strieter RM. Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol 2001;2:285-6.
4. Hall JM, Korach KS. Stromal cell-derived factor-1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 2003;17:792-803.
5. Barbero S, Bonavia R, Bajetto A, et al. Stromal cell-derived factor-1α stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003;63:1969-74.
6. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6.
7. Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B cell growth stimulating factor. Proc Natl Acad Sci U S A 1994;91:2305-9.
8. Mbemba E, Gluckman JC, Gattegno L. Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1α. Glycobiology 2000;10:21-9.
9. Lortat-Jacob H, Grosdidier A, Imberty A. Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci USA 2002;99:1229-34.
10. Geminder H, Sagi-Assif O, Goldberg L, et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001;167:4747-57.
11. Kryczek I, Lange A, Mottram P, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 2005;65:465-72.
12. Gotte M. Syndecans in inflammation. FASEB J 2003;17:575-91.
13. Zimmermann P, David G. The syndecans, tuners of transmembrane signaling. FASEB J 1999;13:S91-100.
14. Carey DJ. Syndecans: multifunctional cell-surface co-receptors. Biochem J 1997;327:1-16.
15. De Parseval A, Bobardt MD, Chatterji A, et al. A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J Biol Chem 2005;280:39493-504.
16. Hamon M, Mbemba E, Charnaux N, et al. A Syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages, and HeLa cell line binds the CXC chemokine, Stromal Cell derived Factor-1 (SDF-1). Glycobiology 2004;14:311-3.
17. Charnaux N, Brule S, Hamon M, et al. Syndecan-4 is a signaling molecule for Stromal Derived-cell Factor-1 (SDF-1)/CXCL12. FEBS J 2005;272:1937-51.
18. Fisher NC, Neil DA, Williams A, Adams DH. Serum concentrations and peripheral secretion of the β chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1α in alcoholic liver disease. Gut 1999;45:416-20.
19. Lichterfeld M, Leifeld L, Nischalke HD, et al. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis 2002;185:1803-7.
20. Marra F. Chemokines in liver inflammation and fibrosis. Front Biosci 2002;7:d1899-914.
21. Mitra P, De A, Ethier MF, et al. Loss of chemokine SDF-1α-mediated CXCR4 signaling and receptor internalization in human hepatoma cell line HepG2. Cell Signal 2001;13:311-9.
22. Vlahakis SR, Villasis-Keever A, Gomez TS, Bren GD, Paya CV. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. J Infect Dis 2003;188:1455-60.
23. Schimanski CC, Bahre R, Gockel I, et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer 2006;95:210-7.
24. Schols D, Struyfs S, Van Damme J, Este JA, Henson G, De Clercq E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997;186:1383-8.
25. Holland JD, Kochetkova M, Akekawatchai C, Dottore M, Lopez A, McColl SR. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Cancer Res 2006;66:4117-24.
26. Lapham CK, Zaitseva MB, Lee S, Romanstseva T, Golding H. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nat Med 1999;5:303-8.
27. Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999;68:729-7.
28. + cells in the absence of other growth factors. Exp Hematol 1995;23:413-21.
29. Miyasaka Y, Enomoto N, Kurosaki M, et al. Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factor-α-mediated apoptosis in HuH7 cells. J Infect Dis 2003;188:1537-44.
30. Nakanishi K, Fujimoto J, Ueki T, et al. Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase. Clin Exp Metastasis 1999;17:507-14.
31. Schwabe RF, Bataller R, Brenner DA. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 2003;285:G949-58.
32. Marra F, Romanelli RG, Giannini C, et al. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999;29:140-8.
33. Yang X, Lu P, Fujii C, et al. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Int J Cancer 2006;118:1869-76.
34. Brand S, Dambacher J, Beigel F, et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 2005;310:117-30.
35. Peng SB, Peek V, Zhai Y, et al. Akt activation, but not extracellular signal-regulated kinase activation is required for SDF-1α/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res 2005;3:227-36.
36. Wang XT, McCullough KD, Wang XJ, Carpenter G, Holbrook NJ. Oxidative stress-induced phospholipase Cγ1 activation enhances cell survival. J Biol Chem 2001;276:28364-71.
37. Mori T, Doi R, Koizumi M, et al. CXCR4 antagonist inhibits stromal cell derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 2004;3:29-37.
38. Scotton CJ, Wilson JL, Scott K, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002;62:5930-8.
39. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375-9.
40. 1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res 2003;63:8312-7.
41. Arii S, Mise M, Harada T, et al. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 1996;24:316-22.
42. Sakamoto Y, Mafune K, Mori M, et al. Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma. Int J Oncol 2000;17:237-43.
43. Quaranta V. Motility cues in the tumor microenvironment. Differentiation 2002;70:590-8.
44. Chaudhuri P, Colles SM, Fox PL, Graham LM. Protein kinase Cδ-dependent phosphorylation of syndecan-4 regulates cell migration. Cire Res 2005;97:674-81.
45. Park H, Kim Y, Lim Y, Han I, Oh ES. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem 2002;277:29730-6.
46. Park H, Han I, Kwon HJ, Oh ES. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells. Cancer Res 2005;65:9899-905.
47. Brule S, Charnaux N, Sutton A, et al. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the Matrix Metalloproteinase-9. Glycobiology 2006;16:488-501.
48. Charnaux N, Sutton A, Brule S, Gattegno L. Regulated shedding of syndecan ectodomains by chemokines. ScientificWorldJournal 2006;6:1037-40.
49. Chi, TY, Chen GG, Lai PB. Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J 2004;10:190-200.
50. Begum NA, Shibuta K, Mori M, Barnard GF. Reduced expression of the CXCR4 receptor mRNA in hepatocellular carcinoma and lack of inducibility of its ligand α-chemokine hIRH/SDF-1α/PBSF in vitro. Int J Oncol 1999;14:927-4.
51. Shibuta K, Mori M, Shimoda K, Inoue H, Mitra P, Barnard GF. Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation. Jpn J Cancer Res 2002;93:789-97.
52. Sutton A, Imbert A, Igoudjil A, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 2005;15:311-9.
53. Lucas M, Mazzone T. Cell surface proteoglycans modulate net synthesis and secretion of macrophage apolipoprotein E. J Biol Chem 1996;271:13454-60.